Buyang Huanwu Decoction Promotes Recovery after Spinal Cord Injury by Regulating cAMP/PKA/NF-κB p65 Pathway
- PMID: 40372579
- DOI: 10.1007/s11655-025-4201-6
Buyang Huanwu Decoction Promotes Recovery after Spinal Cord Injury by Regulating cAMP/PKA/NF-κB p65 Pathway
Abstract
Objective: To investigate whether Buyang Huanwu Decoction (BYHWD) had a good curative effect on the neuroprotection of red nucleus neurons after spinal cord injury (SCI) and the possible molecular mechanism.
Methods: Ninety male Sprague-Dawley rats were divided into 5 groups (n=18 per group) according to a random number table, including the control, model, low- (12.78 g/kg, BL group), medium- (25.65 g/kg, BM group), and high-dose BYHWD groups (51.30 g/kg, BH group). A rubrospinal tract transection model in rats was established, and different doses of BYHWD were intragastrically administrated for 4 weeks. The forelimb locomotor function was recorded using the spontaneous vertical exploration test. Cyclic adenosine monophosphate (cAMP) level in red nucleus was detected through an enzyme-linked immunosorbent assay. The morphology and number of red nucleus neurons were observed using Nissl's staining and axonal retrograde tracing by Fluoro-Gold (FG). The expression of cAMP-dependent protein kinase A (PKA), nuclear factor kappa-B (NF-κB) p65, and brain-derived neurotrophic factor (BDNF) in red nucleus were detected using immunohistochemistry and quantitative real-time polymerase chain reaction.
Results: Compared with the control group, the utilization rate of bilateral forelimbs, unilateral right forelimbs, proportion of FG-labeled positive neurons, cAMP level, protein expressions of PKA and BDNF, and BDNF mRNA expression were significantly decreased in the model group (P<0.01), while NF-κB p65 was increased in the model group (P<0.01). Compared with the model group, the utilization rate of bilateral forelimbs and unilateral right forelimbs were significantly higher in the BL, BM and BH groups (P<0.01), the proportion of FG-labeled positive neurons, cAMP level, protein expressions of PKA and BDNF and BDNF mRNA expression in all BYHWD groups were increased (P<0.05 or P<0.01), while NF-κB p65 were decreased in all BYHWD groups (P<0.05 or P<0.01).
Conclusions: BYHWD possesses a sound neuroprotective effect on red nucleus neurons after SCI, and the efficacy was dose-related. The mechanism may be related to regulating the cAMP/PKA/NF-κ B p65 signaling pathway, finally promoting expression of BDNF.
Keywords: Buyang Huanwu Decoction; Chinese medicine; brain-derived neurotrophic factor; cyclic adenosine monophosphate; nuclear factor kappa-B; protein kinase a; spinal cord injury.
© 2025. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Conflict of Interest. The authors declare that there is no conflict of interest in the publication of this article.
Similar articles
-
Buyang huanwu decoction combined with BMSCs transplantation promotes recovery after spinal cord injury by rescuing axotomized red nucleus neurons.J Ethnopharmacol. 2019 Jan 10;228:123-131. doi: 10.1016/j.jep.2018.09.028. Epub 2018 Sep 25. J Ethnopharmacol. 2019. PMID: 30266421
-
[Mechanisms of Neiyiting Decoction in Preventing Postoperative Recurrence of Endometriosis by Inhibiting Macrophage M1 Polarization Through the TREM1/TLR4/NF-κB Signaling Pathway].Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):371-381. doi: 10.12182/20250360601. Sichuan Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40599271 Free PMC article. Chinese.
-
[Effect and mechanism of Buyang Huanwu Decoction in improving neurological function in ischemic stroke rats based on IRE1α/ASK1/JNK pathway].Zhongguo Zhong Yao Za Zhi. 2025 Jul;50(14):3857-3867. doi: 10.19540/j.cnki.cjcmm.20250416.501. Zhongguo Zhong Yao Za Zhi. 2025. PMID: 40904072 Chinese.
-
Methodological and reporting quality evaluation of Buyang Huanwu decoction for experimental cerebral ischemia-reperfusion injury: a systematic review.Naunyn Schmiedebergs Arch Pharmacol. 2023 May;396(5):831-849. doi: 10.1007/s00210-022-02362-9. Epub 2023 Jan 13. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36637472 Free PMC article.
-
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004863. doi: 10.1002/14651858.CD004863.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004863. doi: 10.1002/14651858.CD004863.pub3. PMID: 16856062 Updated.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical